Synalloy Acquires Leading Specialty Chemicals Contract Manufacturer DanChem
Synalloy Corporation (NASDAQ: SYNL) has successfully acquired DanChem for
- Acquisition of DanChem for $32.95 million enhances product development capabilities.
- DanChem expected to generate approximately $30 million in revenue in 2021 with an 18% adjusted EBITDA margin.
- DanChem's facilities allow for significant expansion and access to new markets like coatings and adhesives.
- Strengthens Synalloy's position as a leading specialty chemical manufacturer in the U.S.
- None.
– Acquisition Enhances Chemicals Management Team, Accelerates Product Development Capabilities, and Provides Entrance into New End-Markets and Applications –
– Synalloy Chemicals is One of the Largest Specialty Chemical Contract Manufacturers in the
DanChem is a leading, full-service specialty chemicals contract manufacturing organization with three production plants located on an owned 55-acre campus in
Under the terms of the agreement,
In 2021, DanChem is expected to generate approximately
Strategic Rationale:
- Acceleration of Product Development Capabilities – DanChem brings leading engineering and process development capabilities with a demonstrated track record of rapidly developing products for commercialization.
- Expansion of Process Offerings – DanChem’s production plants and horizontal reactors drastically accelerate the long-term investment plans of Synalloy Chemicals, providing differentiated assets, rail access and meaningful site acreage for continued expansion.
- Larger Presence in Target End-Markets and Applications – DanChem brings additional customer relationships in target markets, including CASE (coatings, adhesives, sealants and elastomers), additives, industrial and agricultural chemistries.
-
Synalloy Chemicals Becomes a Scaled Platform Capable of Accelerated Growth – DanChem positions Synalloy Chemicals as one of the largest specialty chemical contract manufacturers in the
U.S. and enhances the Company’s ability to be a preferred acquirer for companies within the industry.
“Acquiring DanChem is a pivotal step forward for
Commenting on the acquisition,
About
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties, including without limitation those identified below, which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements. The following factors could cause actual results to differ materially from historical results or those anticipated: adverse economic conditions, including risks relating to the impact and spread of and the government’s response to COVID-19; inability to weather an economic downturn; the impact of competitive products and pricing; product demand and acceptance risks; raw material and other increased costs; raw material availability; financial stability of the Company’s customers; customer delays or difficulties in the production of products; loss of consumer or investor confidence; employee relations; ability to maintain workforce by hiring trained employees; labor efficiencies; risks associated with acquisitions; environmental issues; negative or unexpected results from tax law changes; inability to comply with covenants and ratios required by the Company’s debt financing arrangements; and other risks detailed from time-to-time in
View source version on businesswire.com: https://www.businesswire.com/news/home/20211025005193/en/
Company
Chief Financial Officer
1-804-822-3260
Investor Relations
Gateway Investor Relations
1-949-574-3860
SYNL@gatewayir.com
Source:
FAQ
What was the acquisition cost of DanChem by Synalloy Corporation?
When did Synalloy complete the acquisition of DanChem?
What revenue is DanChem expected to generate in 2021?
What are the strategic benefits of acquiring DanChem for Synalloy?